Note: the website of the health plan administrator Enthea can be found at enthea.com. This organization has no affiliation with our research project.
Enthea is a research project assessing the hypothesis that the world would be better if more people had experiences with psychedelics.
We started out with a focus on psilocybin, and have since broadened our scope to consider many psychedelic drugs.
psychedelic.direct is a good resource for learning about how to start contributing to the psychedelic renaissance.
If you're interested in learning more about Enthea, or want to get involved, shoot us at note at firstname.lastname@example.org
At the start of this project, our belief is that psilocybin is a useful drug. We believe that more psilocybin use would be good, both for the individuals using it and for society at large. The meat of this project is figuring out whether this belief is correct.
Our initial positive impression comes from a first-pass look at the literature. In particular, Dos Santos et al. (2016) is a recent systematic review that notes the utility of psilocybin as a treatment for depression, anxiety, and alcohol & nicotine addiction. Griffiths et al. (2006) and its 14-month follow-up show psilocybin use to have powerful, enduring, positive effects on healthy subjects.